Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Reis-Mendes

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
The Journal of Sports Medicine and Physical Fitness|May 24, 2021
Splenic morphologic changes induced by a strenuous and exhaustive training program in Wistar ratsSara Maia, Beshoy Girgis, Grace F Nunes, et al.
Interdisciplinary Toxicology|September 6, 2018
Pixantrone, a new anticancer drug with the same old cardiac problems? An in vitro study with differentiated and non-differentiated H9c2 cellsAna Reis-Mendes, Marisa Alves, Félix Carvalho, et al.
Pharmaceuticals (Basel, Switzerland)|November 25, 2023
The Metabolic Fingerprint of Doxorubicin-Induced Cardiotoxicity in Male CD-1 Mice Fades Away with Time While Autophagy IncreasesSofia Reis Brandão, Ana Reis-Mendes, Maria João Neuparth, et al.
Biomolecules|March 14, 2019
The Main Metabolites of Fluorouracil + Adriamycin + Cyclophosphamide (FAC) Are Not Major Contributors to FAC Toxicity in H9c2 Cardiac Differentiated CellsAna Reis-Mendes, Félix Carvalho, Fernando Remião, et al.
Archives of Toxicology|October 10, 2022
Autophagy (but not metabolism) is a key event in mitoxantrone-induced cytotoxicity in differentiated AC16 cardiac cellsAna Reis-Mendes, Félix Carvalho, Fernando Remião, et al.
Biomolecules|January 13, 2019
Doxorubicin Is Key for the Cardiotoxicity of FAC (5-Fluorouracil + Adriamycin + Cyclophosphamide) Combination in Differentiated H9c2 CellsMaria Pereira-Oliveira, Ana Reis-Mendes, Félix Carvalho, et al.
Biomolecules|June 28, 2023
Cardiac Molecular Remodeling by Anticancer Drugs: Doxorubicin Affects More Metabolism While Mitoxantrone Impacts More Autophagy in Adult CD-1 Male MiceSofia Reis Brandão, Ana Reis-Mendes, Margarida Duarte-Araújo, et al.
Toxicology|July 11, 2021
Exploring the aging effect of the anticancer drugs doxorubicin and mitoxantrone on cardiac mitochondrial proteome using a murine modelSofia Reis Brandão, Ana Reis-Mendes, Pedro Domingues, et al.
Cardiovascular Toxicology|February 12, 2024
Comparative In Vitro Study of the Cytotoxic Effects of Doxorubicin's Main Metabolites on Cardiac AC16 Cells Versus the Parent DrugAna Reis-Mendes, Cláudia Vitorino-Oliveira, Mariana Ferreira, et al.
Free Radical Biology & Medicine|July 26, 2024
Enduring metabolic modulation in the cardiac tissue of elderly CD-1 mice two months post mitoxantrone treatmentSofia Reis Brandão, Pedro Fontes Oliveira, Bárbara Guerra-Carvalho, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
The Journal of Sports Medicine and Physical Fitness|May 24, 2021
Splenic morphologic changes induced by a strenuous and exhaustive training program in Wistar ratsSara Maia, Beshoy Girgis, Grace F Nunes, et al.
Interdisciplinary Toxicology|September 6, 2018
Pixantrone, a new anticancer drug with the same old cardiac problems? An in vitro study with differentiated and non-differentiated H9c2 cellsAna Reis-Mendes, Marisa Alves, Félix Carvalho, et al.
Pharmaceuticals (Basel, Switzerland)|November 25, 2023
The Metabolic Fingerprint of Doxorubicin-Induced Cardiotoxicity in Male CD-1 Mice Fades Away with Time While Autophagy IncreasesSofia Reis Brandão, Ana Reis-Mendes, Maria João Neuparth, et al.
Biomolecules|March 14, 2019
The Main Metabolites of Fluorouracil + Adriamycin + Cyclophosphamide (FAC) Are Not Major Contributors to FAC Toxicity in H9c2 Cardiac Differentiated CellsAna Reis-Mendes, Félix Carvalho, Fernando Remião, et al.
Archives of Toxicology|October 10, 2022
Autophagy (but not metabolism) is a key event in mitoxantrone-induced cytotoxicity in differentiated AC16 cardiac cellsAna Reis-Mendes, Félix Carvalho, Fernando Remião, et al.
Biomolecules|January 13, 2019
Doxorubicin Is Key for the Cardiotoxicity of FAC (5-Fluorouracil + Adriamycin + Cyclophosphamide) Combination in Differentiated H9c2 CellsMaria Pereira-Oliveira, Ana Reis-Mendes, Félix Carvalho, et al.
Biomolecules|June 28, 2023
Cardiac Molecular Remodeling by Anticancer Drugs: Doxorubicin Affects More Metabolism While Mitoxantrone Impacts More Autophagy in Adult CD-1 Male MiceSofia Reis Brandão, Ana Reis-Mendes, Margarida Duarte-Araújo, et al.
Toxicology|July 11, 2021
Exploring the aging effect of the anticancer drugs doxorubicin and mitoxantrone on cardiac mitochondrial proteome using a murine modelSofia Reis Brandão, Ana Reis-Mendes, Pedro Domingues, et al.
Cardiovascular Toxicology|February 12, 2024
Comparative In Vitro Study of the Cytotoxic Effects of Doxorubicin's Main Metabolites on Cardiac AC16 Cells Versus the Parent DrugAna Reis-Mendes, Cláudia Vitorino-Oliveira, Mariana Ferreira, et al.
Free Radical Biology & Medicine|July 26, 2024
Enduring metabolic modulation in the cardiac tissue of elderly CD-1 mice two months post mitoxantrone treatmentSofia Reis Brandão, Pedro Fontes Oliveira, Bárbara Guerra-Carvalho, et al.
Pageof 3